'Escobar' Conundrum: 2017's Biggest Story In Medtech False-Claims Enforcement
Executive Summary
A Supreme Court decision that established a new standard in False Claims Act cases was key to FCA enforcement in 2017, when FCA enforcement remained a priority under the Trump administration.
You may also be interested in...
False Claims Act Update Finds More Clarity On 'Escobar'
Courts have been busy with False Claims Act-related cases in the first half of 2018 despite a lack of device-specific settlements, new analysis from law firm Gibson Dunn shows. Of particular interest: New rulings that show courts settling on a unified interpretation of the Supreme Court’s 2017 Escobar ruling.
Mid-Year Enforcement Roundup: Focus On Opioids, As Other Areas Lag
A recent report from law firm Gibson Dunn seems to show that the Trump administration, while aggressively pursuing opioid enforcement actions, slowed down enforcement in other areas during the first half of 2018. But important case-law developments continue.
US DoJ Memos May Hint At Enforcement Stepdown
The US Department of Justice has ordered its attorneys to ask for the dismissal of more whistleblower cases, and to avoid basing civil enforcement actions solely on guidance documents. Both could lead to fewer enforcement actions against device manufacturers.